GV118819X, a novel tricyclic beta-lactam antibiotic of GlaxoWellcome, is a
racemic mixture of two diastereoisomers, A and B, Of the two diastereoisome
rs, only A is available as a pure compound. By analyzing mixtures of GV1188
19X and A, a partial phase diagram is constructed, which indicates the pres
ence of a eutectic when the A fraction is similar to 39%. Moreover, the mel
ting enthalpies of the eutectic mixture and of diastereoisomer B can be est
imated. With the exception of the pure A form, all mixtures undergo importa
nt modifications in morphology and microstructure as a consequence of therm
al treatments, which induce melting/amorphization of the eutectic, and crys
tallization of the A form. Analyses of the sieved fractions of GV118819X de
monstrate that it consists of acicular crystals of different composition, w
ith the larger crystals having a larger A fraction than the smaller ones. G
rinding causes melting/amorphization of the eutectic and, following hours-l
ong treatments, the formation of a substantial fraction of submicron partic
les with unusually low melting temperatures. (C) 2000 Wiley-Liss, Inc.